RCA
LLY icon

Riverview Capital Advisers’s Eli Lilly LLY Stock Holding History

Riverview Capital Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$468K Hold
509
– – 0.16% 57
2025
Q4 		$547K Buy
509
+14
+3% +$13.4K 0.17% 61
2025
Q3 		$378K Buy
+495
New +$368K 0.11% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Riverview Capital Advisers's LLY Position: Q1 2026 in Review

Riverview Capital Advisers held its Eli Lilly (LLY) position steady in Q1 2026 at 509 shares worth $468K. The position accounts for 0.16% of the portfolio, ranked #57.

Riverview Capital Advisers first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. The position peaked at $547K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Riverview Capital Advisers held 509 shares of Eli Lilly worth $468K as of Q1 2026.
  • Riverview Capital Advisers left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.16% of Riverview Capital Advisers's portfolio in Q1 2026, its #57 holding.
  • Riverview Capital Advisers first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • Riverview Capital Advisers's Eli Lilly position peaked at $547K in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Riverview Capital Advisers's 13F filing for Q1 2026, filed 14 May 2026.